StephenJosephPeroutkaMD

PubMed

• 308 citations
  Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes
  Richard E. Heuring, Stephen J. Peroutka
  The Journal of Neuroscience. 1987-03-01
• 81 citations
  Species variations in RU 24969 interactions with non-5-HT1A binding sites.
  Richard E. Heuring, Jerry R. Schlegel, Stephen J. Peroutka
  European Journal of Pharmacology. 1986-03-18
• 103 citations
  NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS
  Stephen J. Peroutka
  Molecular Interventions. 2005-10-01

Journal Articles

• Clinical Trials Update 2013: the year in review  
  Peroutka SJ, Headache, 1/1/2014
• Calcitonin gene-related peptide targeted immunotherapy for migraine: progress and challenges in splitting the headache  
  Peroutka SJ, BioDrugs, 1/1/2014
• Clinical Trials Update 2012: the year in review  
  Peroutka SJ, Headache, 1/1/2013
• Not all CGRP antagonists are created equal  
  Peroutka SJ, Headache, 1/1/2013
• Clinical Trials Update 2011: the year in review  
  Peroutka SJ, Headache, 1/1/2012
• Clinical Trials Update 2010: the year in review  
  Peroutka SJ, Headache, 1/1/2011
• Clinical Trials Update 2009: the year in review  
  Peroutka SJ, Headache, 1/1/2010
• Clinical Trials Update 2008: the year in review  
  Peroutka SJ, Headache, 1/1/2009
• Neurogenic inflammation and migraine: implications for therapeutics  
  Peroutka SJ, Mol Interv, 1/1/2005
• Migraine: A chronic sympathetic nervous system disorder  
  Peroutka SJ, Headache, 1/1/2004
• A randomized, double-blind, crossover study of the efficacy of 100 mg diclofenac sodium softgel formulation with or without 100 mg caffeine in the acute treatment of m...  
  Peroutka SJ, Lyon JA, Swarbrick J, Lipton RB, Kolodner K, Goldstein J, Headache, 1/1/2004
• A Sympathetic View of “2003 Wolff Award: Possible Parasympathetic Contributions to Peripheral and Central Sensitization During Migraine”  
  Peroutka SJ, Headache, 1/1/2004
• Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain  
  Zuniga JR, Phillips CL, Shugars D, Lyon JA, Peroutka SJ, , Swarbrick J, Bon C, Journal of Oral and Maxillofacial Surgery, 1/1/2004
• Serum glucose regulation and headache  
  Peroutka SJ, Headache, 1/1/2002
• Sympathetic look at genetic basis of migraine  
  Peroutka SJ, Headache, 1/1/2002
• Glucose regulation in headache: Implications for dietary management  
  Hufnagl KN, Peroutka SJ, Expert Reviews in Neurotherapeutics, 1/1/2002
• Analysis of Internet sites for headache  
  Peroutka SJ, Cephalalgia, 1/1/2001
• Medical utility of apoe allele determination in assessing the need for antioxidant therapy  
  Dreon DM, Peroutka SJ, Medical Hypotheses, 1/1/2001
• Single nucleotide polymorphism (SNP) alleles in the Insulin Receptor (INSR) gene are associated with typical migraine  
  McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, Peroutka SJ, Griffiths LR, Boyd PR, Lea RA, Bhatti SM, Hosking LK, Hood CM, Jones KW, Handley AR, Rall..., Genomics, 1/1/2001
• Migraine with Aura Susceptibility Locus on Chromosome 19p13 is Distinct from the Familial Hemiplegic Migraine Locus  
  Jones KW, Ehm MG, Boyd PR, Peroutka SJ, Genomics, 1/1/2001
• Review of “Migraine and Headache Pathophysiology”  
  Peroutka SJ, Headache, 1/1/2000
• The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation  
  Peroutka SJ, Dreon DM, European Journal of Pharmacology, 1/1/2000
• Molecular variation within the dopamine receptor DRD2 gene in migraine  
  Peroutka SJ, The Journal of Headache and Pain, 1/1/2000
• Detection of mRNAs and alternatively spliced transcripts of dopamine receptors in rat peripheral sensory and sympathetic ganglia  
  Xie GX, Jones KW, Peroutka SJ, Palmer PP, Brain Research, 1/1/1998
• Comorbid migraine, anxiety and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles  
  Peroutka SJ, Price SC, Wilhoit TL, Jones KW, Molecular Medicine, 1/1/1998
• Join now to see all

Books/Book Chapters

• Autonomic Failure 
  Chapter: The molecular genetics of the autonomic nervous system 
  Peroutka SJEditors: Mathias CJ, Bannister R.Oxford University PressEdition 5th,2013
• Principals of Drug Therapy in Neurology 
  Chapter: Migraine 
  Page 152 - 172Peroutka SJEditors: Johnston MV and Gross RA.Oxford University PressEdition 2nd,2008
• Molecular Neurology 
  Chapter: Genetic Disorders of the Autonomic Nervous System 
  Page 321 - 332Peroutka SJEditors: Stephen G. Waxman.Elsevier2007
• Hot Topics in Headache: The Migraine Trust 
  Chapter: Take these two websites and call me in the morning 
  Page 78 - 80Peroutka SJEditors: Swain D.2002
• Hot Topics in Headache: The Migraine Trust 
  Chapter: Headache doctors and headache patients working together 
  Page 16 - 20Peroutka SJEditors: Swain D.2002
• Harrison’s Principles of Internal Medicine 
  Chapter: Headache, including migraine and cluster headache 
  Page 70 - 79Raskin NH, Peroutka SJEditors: Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL.Edition 15th,2001
• Genetics of Headache Disorders 
  Chapter: Experience from other complex disorders: The utility of genetic association studies 
  Peroutka SJEditors: Olesen J.Lippincott-Raven Publishers, Philadelphia, PA2000
• The Management of Acute and Chronic Pain the Use of the “Tools of the Trade” (Proceedings of the “Worldwide Pain Congress”) 
  Chapter: Analysis of Internet sites for pain 
  Page 109 - 115Peroutka SJ, Dreon DMEditors: Krames E, Reig E.2000
• Autonomic Failure 
  Chapter: Molecular genetic approaches to the autonomic nervous system 
  Page 33 - 36Peroutka SJEditors: Mathias CJ, Bannister R.Oxford University Press1999
• Encyclopedia of Neuroscience 
  Chapter: Serotonin (5-hydroxytryptamine) receptor subtypes: Clinical relevance 
  Page 1842 - 1845Peroutka SJ, Mahler EEditors: Adelman GA, Smith BH.Edition 2nd,1999
• Principals of Medical Biology Volume 8A: Molecular & Celular Pharmacology 
  Chapter: 5-Hydroxytryptamine receptors 
  Page 61 - 74Peroutka SJ, Howell TAEditors: Bittar EE, Bittar N.JAI Press, Inc.1997
• Serotonin Receptors and Their Ligands 
  Chapter: 5-Hydroxytryptamine receptor subtypes 
  Page 3 - 13Peroutka SJEditors: Olivier B, Van Wijngaarden I, Soudijn W.Elsevier Science B.V., Amsterdam1997
• Functional Genomics: Drug Discovery from Gene to Screen, IBC Biomedical Library Series 
  Chapter: Multi-phenotypic Allelic Profiling: A novel strategy for functional genomics 
  Peroutka SJInternational Business Communications, Inc., Southborough, MA1997
• Blue Books of Practical Neurology: Headache 
  Chapter: The genetic evaluation of migraine 
  Page 107 - 114Peroutka SJEditors: Goadsby PJ and Silberstein SD.Butterworth Heinemann, Newton, MA1997
• Towards Migraine 2000 
  Chapter: The genetic evaluation of migraine: Clinical database requirements 
  Page 35 - 48Peroutka SJ, Howell TAEditors: Rose FC.Elsevier Science B.V.1996
• Goodman and Gilman's The Pharmacological Basis of Therapeutics 
  Chapter: Drugs effective in the treatment of migraine 
  Page 487 - 502Peroutka SJEditors: Hardman JG and Limbird LE.Edition 9th,1995
• Experimental Headache Models 
  Chapter: Future development of drugs for headache disorders 
  Page 345 - 349Peroutka SJEditors: Olesen J and Moskowitz MA.Lippincott-Raven Publishers, Philadelphia, PA1995
• Handbook of Receptors and Channels: G Protein-coupled Receptors 
  Editors: Peroutka SJ.CRC Press, Boca Raton, FL1994
• 50 Years of LSD: Current status and perspectives of hallucinogens 
  Chapter: 5-Hydroxytryptamine receptor interactions of D-lysergic acid diethylamide 
  Page 19 - 26Peroutka SJEditors: Pletscher A, Ladewig D.1994
• Serotonin (5-HT) in neurologic and psychiatric disorders 
  Chapter: Evolution of 5-HT receptors and clinical relevance 
  Page 29 - 38Peroutka SJ, Howell TAEditors: Ferrari D.1994
• CRC Handbook of Receptors and Channels: G Protein-coupled Receptors 
  Chapter: 5-Hydroxytryptamine receptors 
  Page 209 - 236Peroutka SJEditors: Peroutka SJ.1994
• CRC Handbook of Receptors and Channels: G Protein-coupled Receptors 
  Chapter: Endothelin receptors 
  Page 125 - 128Peroutka SJEditors: Peroutka SJ.1994
• Proceedings of the 26th Annual Recent Advances in Neurology 
  Chapter: Thrombolytic agents in acute stroke 
  Page 106 - 114Peroutka SJUniversity of California at San Francisco School of Medicine, San Francisco, CA1993
• Headache: A Clinician's Guide to Diagnosis, Pathophysiology and Treatment Strategies 
  Chapter: Serotonin receptor pharmacology in migraine 
  Page 19 - 23Peroutka SJEditors: Rapaport AM, Sheftell F.PMA Publishing Company, Los Alamitos1993
• Trends in Drug Research 
  Chapter: Pharmacochemistry of 5-HT receptor subtype selective compounds 
  Page 83 - 95Peroutka SJEditors: V. Claassen.1993
• Join now to see all

Abstracts/Posters

• NGX-1998: Phase 2 Proof of Concept Study in Postherpetic Neuralgia Using a Novel Topical Liquid Formulation of Capsaicin
  Peroutka SJ, Tobias J, Vanhove G, Bhattacharya S, 14th World Congress on Pain Abstracts, 1/1/2012
• Prostaglandins in Migraine: The Headache Stuff of Harold G. Wolff
  Peroutka SJ, Cephalalgia, 1/1/2004
• Molecular Pathway Analysis of Allodynia: The Primary Role of Prostaglandins
  Peroutka SJ, Headache, 1/1/2004
• In Memoriam: The Neurogenic Theory of Migraine (1979-2004)
  Peroutka SJ, Headache, 1/1/2004
• Migraine: A chronic sympathetic nervous system disorder
  Peroutka SJ, Headache, 1/1/2003
• The efficacy of existing acute migraine agents: The need for improved clinical approaches to the acute management of migraine
  Peroutka SJ, Headache, 1/1/2003
• Pharmacological analysis existing prophylactic migraine agents: Inhibition of sympathetic nervous system activation as a common mechanism of action
  Peroutka SJ, Cephalalgia, 1/1/2003
• Single nucleotide polymorphism (SNP) alleles in the Insulin Receptor (INSR) gene are associated with migraine
  White NJ, Hosford DA, Humphrey PP, Boyd PR, Griffiths LR, Peroutka S, Roses AD, Purvis IJ, McCarthy LC, Cephalalgia, 1/1/2001
• A randomized, double-blind, crossover study of the efficacy of a 100 mg diclofenac sodium softgel formulation with or without 100 mg caffeine in the acute treatment of...
  Goldstein J, Lipton R, Kolodner K, Swarbrick J, Lyon J, Dreon D, Peroutka S, Cephalalgia, 1/1/2001
• Analgesic safety and efficacy of diclofenac softgels in postoperative dental pain
  Zuniga J, Phillips C, Shugars D, Rogers L, Lyon J, Peroutka S, Swarbrick J, Journal of Oral and Maxillofacial Surgery, 1/1/2001
• Migraine 2000: Beyond the triptans
  Peroutka S, Gebhart G, McCall R, Mermelstein P, Abstracts of the Thirty-third Annual Winter Conference on Brain Research, 1/1/2000
• Analysis of Internet sites for headache
  Peroutka SJ, The 13th Annual Practicing Physician’s Approach to the Difficult Headache Patient Abstracts, 1/1/2000
• Analysis of Internet sites for migraine
  Peroutka SJ, Abstracts of the 42nd Annual Scientific Meeting of the American Headache Society, 1/1/2000
• Analysis of Internet sites for pain
  Dreon DM, Peroutka SJ, Worldwide Pain Congress Abstracts, 1/1/2000
• Sensitivity of the four level categorical scale vs. The visual analogue scale in assessing headache pain intensity in migraineurs
  Dreon DM, Peroutka SJ, Cephalalgia, 1/1/2000
• Effect of metoclopramide and caffeine on the rapid oral absorption of diclofenac
  Swarbrick J, Lyon, Jr. JA, Peroutka SJ, Cephalalgia, 1/1/2000
• A proposed editorial review system for “headache” information on the internet
  Peroutka SJ, Cephalalgia, 1/1/2000
• Serotonin receptor variants in disease: New therapeutic opportunities
  Peroutka SJ, Abstracts of the Symposium on Serotonin Receptors, 10/1/1997
• New advances in the treatment of migraine
  McCall RB, Phebus L, Hall E, Gebhart G, Peroutka S, Abstracts of the Thirtieth Annual Winter Conference on Brain Research, 1/1/1997
• Autosomal dominant vertical and horizontal nystagmus: A vestibulocerebellar syndrome that does not map to chromosome 19p
  May EF, Stankus SJ, Coughlin WF, Jones KW, Peroutka SJ, Neurology, 1/1/1997
• Beyond monotherapy: Rational polytherapy in migraine
  Peroutka SJ, Headache, 1/1/1997
• Mendelian inheritance of comorbid migraine, anxiety and depression
  Peroutka SJ, Mahler E, Price SC, Headache, 1/1/1997
• Polymorphisms within the CACN1A4 gene are not associated with migraine without aura or migraine with aura
  Peroutka SJ, Wilhoit TL, Boatwright M, Derksen M, Jones KW, Headache, 1/1/1997
• Experience from other complex disorders: The utility of association genetic studies
  Peroutka SJ, Abstracts of the 8th International Headache Research Seminar, 1/1/1997
• A novel clinical mapping strategy based on a multi-phenotypic analyses of polymorphisms
  Jones KW, Xie GX, Peroutka SJ, American Society for Human Genetics Abstracts, 1/1/1996
• Join now to see all

Lectures

• CGRP and Migraine 
  Baltimore, MD - 4/1/2014
• Migraine pain: what have we learned to date? 
  London, England - 10/1/2009
• The Biological Basis of Migraine 
  Kyoto, Japan - 10/1/2005
• Migraine and Neuronal Hyperexcitability: Insights for Therapy 
  Washington, DC - 3/1/2005
• A Sympathetic Look at Migraine 
  Bern, Switzerland - 8/1/2004
• Migraine and the Sympathetic Nervous System 
  Rotterdam, Netherlands - 5/1/2003
• Molecular Variation within Dopamine Receptor Genes in Migraine 
  Rome, Italy - 9/1/2000
• Media Medicine: Educating the 21st Century Headache Patient 
  London, United Kingdom - 9/1/2000
• The role of dopamine in migraine 
  Osaka, Japan - 4/1/1999
• Genetic analysis of complex disorders 
  Copenhagen, Denmark - 11/1/1997
• Multi-phenotypic Allelic Profiling 
  Monte Carlo, Monaco - 5/1/1997
• A Novel Clinical Mapping Strategy 
  Vancouver, Canada - 4/1/1996
• An overview of the genetics of migraine 
  Toronto, Canada - 9/1/1995
• The Genetic Basis of Migraine: The Future is Now 
  Leeds Castle, United Kingdom - 6/1/1995
• Future approaches to the development of novel headache therapeutics 
  Copenhagen, Denmark - 11/1/1994
• Mechanisms underlying migraine and therapeutic consequences 
  Vienna, Austria - 9/1/1994
• 5-HT receptors and clinical relevance 
  Copenhagen, Denmark - 9/1/1994
• Evolution of 5-HT receptors and clinical relevance 
  Leiden, Netherlands - 5/1/1994
• Serotonergic receptor interactions of LSD 
  Agno, Switzerland - 10/1/1993
• Anti-migraine drug interactions with human 5-HT1 receptors 
  Paris, France - 8/1/1993
• Pharmacochemistry of 5-HT Compounds 
  Noordwijkerhout, Netherlands - 5/1/1993
• Neurotrophic Factors and Diseases of the Aging Nervous System 
  San Francisco, CA - 10/1/1992
• The molecular biology of 5-HT receptor subtypes 
  Birmingham, England - 7/1/1991
• Basic mechanisms of action of anti-migraine drugs 
  Washington, DC - 7/1/1991
• Recent advances in the pharmacology of migraine 
  London, Ontario - 10/1/1990
• Join now to see all

Other

• Step-wise analysis of polymorphisms in the human dopamine D2 receptor gene 
  Jones KW, Peroutka SJ
  1/1/1998